Profusa (PFSA) director awarded 274,660 stock options at $0.35

Rhea-AI Filing Summary

Profusa, Inc. director Peter O’Rourke reported two stock option awards on Profusa (PFSA) common stock. On January 26, 2026, he received options for 221,794 shares and a separate award for 52,866 shares, both with a $0.35 exercise price.

The larger grant is an inaugural director award that vests in three equal annual installments over three years from the closing of the business combination between NorthView Acquisition Corp. and Profusa. The second grant is an annual director award vesting on the first anniversary of that closing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Rourke Peter

(Last) (First) (Middle)

626 BANCROFT WAY, SUITE A

(Street)

BERKELEY CA 94710

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Profusa, Inc. [ PFSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$0.35	01/26/2026		A		221,794(1)		01/26/2026	01/26/2036	Common Stock	221,794	$0	221,794	D
Stock Options	$0.35	01/26/2026		A		52,866(2)		01/26/2026	01/26/2036	Common Stock	52,866	$0	52,866	D

Explanation of Responses:

1. Represents an inaugural director award of options to purchase common stock. The options vest in three equal annual increments over a period of three years from the closing of the business combination between the Issuer (formerly known as NorthView Acquisition Corp.) and Profusa, Inc. (the "Closing").

2. Represents an annual director award of options to purchase common stock. The options vest on the first anniversary of the Closing.

	/s/ Peter O Rourke	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Profusa (PFSA) director Peter O’Rourke’s Form 4 report?

The Form 4 reports that director Peter O’Rourke received two stock option awards in Profusa common stock on January 26, 2026. These derivative grants are director compensation and were acquired at no cost, subject to specific vesting schedules tied to the company’s business combination closing.

How many Profusa (PFSA) stock options were granted to Peter O’Rourke?

Peter O’Rourke received two separate stock option awards: one for 221,794 options and another for 52,866 options. Each option relates to Profusa common stock as the underlying security and represents part of his compensation for board service as a director of the company.

What is the exercise price of Peter O’Rourke’s Profusa (PFSA) stock options?

Both option grants carry a conversion or exercise price of $0.35 per share of Profusa common stock. The options themselves were acquired for $0, meaning no purchase price was paid at grant, but $0.35 per share would be payable upon future exercise of the options.

How do the Profusa (PFSA) director stock options to Peter O’Rourke vest?

The inaugural director option award for 221,794 shares vests in three equal annual installments over three years from the business combination closing. The annual director award for 52,866 shares vests in full on the first anniversary of that same closing, assuming continued eligibility under the terms.

What is the role of Peter O’Rourke at Profusa (PFSA) according to the Form 4?

Peter O’Rourke is identified as a director of Profusa, Inc. on the Form 4, with the filing marked as being submitted by one reporting person. The reported stock option awards reflect director compensation rather than open-market share purchases or sales of existing Profusa common stock.

Are Peter O’Rourke’s Profusa (PFSA) option holdings reported as direct or indirect ownership?

The Form 4 shows Peter O’Rourke’s option holdings as directly owned. After the January 26, 2026 grants, he directly holds 221,794 options from the inaugural director award and 52,866 options from the annual director award, each tied to Profusa common stock as the underlying security.